Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NewGenIvf Group Limited Class A Ordinary Shares (NIVF)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: NIVF (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -1.52% | Avg. Invested days 109 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 4.45M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.13 | 52 Weeks Range 0.26 - 45.40 | Updated Date 06/29/2025 |
52 Weeks Range 0.26 - 45.40 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -293.1 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.66% | Operating Margin (TTM) -85.51% |
Management Effectiveness
Return on Assets (TTM) -17.99% | Return on Equity (TTM) -53.76% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 7113172 | Price to Sales(TTM) 0.82 |
Enterprise Value 7113172 | Price to Sales(TTM) 0.82 | ||
Enterprise Value to Revenue 1.31 | Enterprise Value to EBITDA 294.99 | Shares Outstanding 4304040 | Shares Floating 112699 |
Shares Outstanding 4304040 | Shares Floating 112699 | ||
Percent Insiders 2.24 | Percent Institutions 0.55 |
Upturn AI SWOT
NewGenIvf Group Limited Class A Ordinary Shares
Company Overview
History and Background
NewGenIvf Group Limited is a fertility service provider, established to offer a range of assisted reproductive technology (ART) services. It focuses on providing advanced fertility treatments and personalized care to patients. The company has expanded its services and network to cater to the growing demand for fertility solutions.
Core Business Areas
- Assisted Reproductive Technology (ART) Services: This includes In-Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Testing (PGT), and other advanced fertility treatments.
- Fertility Counseling and Consultation: Providing comprehensive counseling and consultation services to individuals and couples seeking fertility assistance.
- Egg Freezing and Sperm Banking: Offering cryopreservation services for eggs and sperm to preserve fertility for future use.
- Andrology Services: Diagnostic and therapeutic services related to male infertility.
Leadership and Structure
Information about the leadership team and organizational structure of NewGenIvf Group Limited Class A Ordinary Shares is not publicly available in detail.
Top Products and Market Share
Key Offerings
- In-Vitro Fertilization (IVF): Core service offered, including ovarian stimulation, egg retrieval, fertilization, and embryo transfer. Market share data is difficult to specify exactly but IVF remains one of the biggest revenue streams for ART. Competitors include Boston IVF, CCRM Fertility, Shady Grove Fertility.
- Intracytoplasmic Sperm Injection (ICSI): Injection of a single sperm into an egg for fertilization. Typically used in cases of male infertility. ICSI market share is also encompassed within the broader ART services. Competitors include Boston IVF, CCRM Fertility, Shady Grove Fertility.
- Preimplantation Genetic Testing (PGT): Screening embryos for genetic abnormalities before transfer. Growing in adoption rates. Competitors include Boston IVF, CCRM Fertility, Shady Grove Fertility.
Market Dynamics
Industry Overview
The fertility services industry is growing globally due to increasing infertility rates, delayed parenthood, and advancements in ART technologies. The market is competitive, with numerous clinics and providers.
Positioning
NewGenIvf Group Limited aims to position itself as a provider of advanced and personalized fertility treatments, differentiating itself through technology and patient care.
Total Addressable Market (TAM)
The global fertility services market is projected to reach billions of dollars. NewGenIvf Group Limited is positioned to capture a share of this market by expanding its services and geographic reach.
Upturn SWOT Analysis
Strengths
- Advanced technology and equipment
- Experienced medical team
- Personalized patient care
- Comprehensive range of fertility services
Weaknesses
- Limited brand recognition compared to larger competitors
- Geographic concentration
- Reliance on specific technologies
- Lack of detailed publicly available data
Opportunities
- Expansion into new geographic markets
- Partnerships with research institutions
- Adoption of new ART technologies
- Increasing awareness of fertility treatments
Threats
- Competition from established fertility clinics
- Regulatory changes in the fertility industry
- Economic downturns impacting patient affordability
- Technological advancements making existing methods obsolete
Competitors and Market Share
Key Competitors
- Boston IVF (private)
- CCRM Fertility (private)
- Shady Grove Fertility (private)
Competitive Landscape
NewGenIvf Group Limited operates in a competitive landscape, facing competition from established players with greater brand recognition and market share. They must differentiate themselves through technology, patient care, or geographic focus.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are difficult to assess due to limited public data.
Future Projections: Future growth projections require detailed financial data and analyst estimates, which are unavailable in sufficient detail.
Recent Initiatives: Recent strategic initiatives include expansion of services and adoption of new technologies to improve success rates and patient experience.
Summary
NewGenIvf Group Limited is a fertility service provider in a growing market. The company has the potential to grow by expanding into new markets, adopting new technologies and building brand awareness. However, the company must deal with competition from established players, regulatory changes, and economic downturns impacting patient affordability and the limited publicly available data makes a deep dive difficult. More information is needed before making a sound investment decision.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- News articles
Disclaimers:
Data and analysis are based on limited publicly available information. Market share data is estimated and may not be precise. Financial data for NewGenIvf Group Limited Class A Ordinary Shares is difficult to obtain. This analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NewGenIvf Group Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-04-03 | Co-Founder, Chairman & CEO Mr. Wing Fung Siu | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 76 | Website https://newgenivf.com |
Full time employees 76 | Website https://newgenivf.com | ||
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.